Skip to main content

Research Repository

Advanced Search

All Outputs (2)

Low temperature plasma: a novel focal therapy for localized prostate cancer? (2014)
Journal Article
Hirst, A. M., Frame, F. M., Maitland, N. J., & O’Connell, D. (2014). Low temperature plasma: a novel focal therapy for localized prostate cancer?. Biomed research international, 2014, Article 878319. https://doi.org/10.1155/2014/878319

Despite considerable advances in recent years for the focal treatment of localized prostate cancer, high recurrence rates and detrimental side effects are still a cause for concern. In this review, we compare current focal therapies to a potentially... Read More about Low temperature plasma: a novel focal therapy for localized prostate cancer?.

DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation (2014)
Journal Article
Pellacani, D., Kestoras, D., Droop, A. P., Frame, F. M., Berry, P. A., Lawrence, M. G., Stower, M. J., Simms, M. S., Mann, V. M., Collins, A. T., Risbridger, G. P., & Maitland, N. J. (2014). DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death and Differentiation, 21(5), 761-773. https://doi.org/10.1038/cdd.2013.202

Prostate cancer (CaP) is mostly composed of luminal-like differentiated cells, but contains a small subpopulation of basal cells (including stem-like cells), which can proliferate and differentiate into luminal-like cells. In cancers, CpG island hype... Read More about DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.